Los Angeles - 
(NewMediaWire) - November 17, 2021 - The Schall Law Firm, a national shareholder rights litigation firm,
announces that it is investigating claims on behalf of investors of Organogenesis
Holdings Inc. (“Organogenesis” or “the
Company”) (NASDAQ: ORGO) for violations of the
securities laws.
The investigation focuses on whether the Company
issued false and/or misleading statements and/or failed to disclose information
pertinent to investors. Organogenesis is the subject of a report published by
Value Investors Club on October 12, 2021. The report alleges that the Company
has improperly billed the government for up to $250 million each year. The
report also claims that the Company set pricing for its wound covering product
Affinity “exorbitantly high,” while making the product extremely lucrative for
doctors through rebates. Based on this report, shares of Organogenesis fell by
14% on the same day.
If you are a shareholder who
suffered a loss, click
here to participate.
We also encourage you to contact
Brian Schall of the Schall Law Firm, 2049
Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also
reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.
The class in this case has not
yet been certified, and until certification occurs, you are not represented by
an attorney. If you choose to take no action, you can remain an absent class
member.
The Schall Law Firm represents
investors around the world and specializes in securities class action lawsuits
and shareholder rights litigation.
This press release may be
considered Attorney Advertising in some jurisdictions under the applicable law
and rules of ethics.
CONTACT:
The Schall
Law Firm
Brian Schall, Esq.
310-301-3335
